INNOVATING DRUG DISCOVERY QGel is dedicated to making in vitro drug discovery more relevant to in vivo biology. QGel in vitro assays are physiologically relevant because they are based on clonogenically-grown cells within designer microenvironments that favour the expression of physiological features normally only seen in vivo or in the clinic. QGel SA was founded in 2009 and is based in the Lake Geneva region of Switzerland.
Looking for a particular QGel employee's phone or email?
The QGel annual revenue was $5.2 million in 2026.
3 people are employed at QGel.
QGel is based in Lausanne, Vaud.
The NAICS codes for QGel are [54171, 54, 541713, 541, 5417].
The SIC codes for QGel are [87, 873].